[1]Chen Y, Hicks A, While AE. Depression and related factors in older people in China: A systematic review[J]. Rev Clin Gerontol, 2012,22(1):52-67.
[2]金一波,杨治良,张红,等.老年抑郁症的症状、诊断及测量[J]. 心理科学,2005,28(4):949-951.
[3]Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data[J]. Lancet Psychiatry,2014,1(5):343-350.
[4]李秀玉.恶性肿瘤与抑郁障碍[J]. CJCM中医临床研究,2012,4(13):1-4.
[5]中华中医药学会血液病分会. 肿瘤相关抑郁状态中医诊疗专家共识[J]. 中华中医药杂志,2015,30(12): 4397-4399.
[6]Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American society of clinical oncology guideline adaptation[J]. J Clin Oncol, 2014,32(15): 1605-1619.
[7]Bielecka AM,Obuchowicz E.Antidepressant drugs as a complementary therapeutic strategy in cancer[J]. Exp Biol Med (Maywood), 2013,238(8):849-858.
[8]张秋菊. 现代医学模式转变面临的挑战与对策分析[J]. 中国医学伦理学,2011,24(3):298-299.
[9]刘慧. 2009-2011年南京地区抗抑郁药物应用分析[J]. 医学综述,2013,19,(18):3455-3457.
[10]李万太. 氟哌噻吨美利曲辛片联合卡托普利治疗高血压合并抑郁焦虑40例[J]. 中国老年学杂志,2013,33(7):3230-3231.
[11]易志强,罗银花,万凤福,等.黛力新对冠心病伴焦虑抑郁症的疗效及生活质量的影响[J]. 现代医药卫生,2014,30(22):3441-3443.
[12]Phillips MR, Zhang J, Shi Q, et al. Prevalence,treatment,and associated disability of mental disorders in four provinces in China during 2001-05:an epidemiological survey[J]. Lancet, 2009, 373(9680):2041-2053.
[13]Muscatello MR, Spina E, Bandelow B, et al. Clinically relevant drug interactions in anxiety disorders[J]. Human Psychopharmacl, 2012,27(3):239-253.
[14]Ferslew KE, Hagardorn AN, Harlan GC, et al. A fatal drug interaction between clozapine and fluoxetine[J]. J Forensic Sci, 1998, 43(5):1082-1085.
[15]Tatonetti NP, Denny JC, Murphy SN, et al. Detecting drug interactions from adverse-event reports:interaction between paroxetine and parvastatin increases blood glucose levels[J]. Clin Pharmacol Ther, 2011, 90(1): 133-142.
[16]Stein DJ, Westenberg HGM, Liebowitz MR. Social anxiety disorder and generalized anxiety disorder:serotonergic and dopaminergic neurocircuitry[J]. J Clin Psychiatry,2002,63(6):12-19.
[17]Barbee JG, Conrad EJ, Jamhour NJ. Aripiprazole augmentation in treatment-resistant depression[J]. Ann Clin Psychiatry,2004,16(4):189-194.